Cisplatin

Form: Injection

Strength: 50 mg/50 mL, 100 mg/100 mL

Reference Brands: Platinol® (EU & US)

Category: Oncology Cancer Care

Cisplatin, marketed as Platinol®, is a platinum-based chemotherapy drug widely used in the treatment of various cancers, including testicular, ovarian, bladder, lung, and head and neck cancers. Available in 50 mg/50 mL and 100 mg/100 mL intravenous formulations, Cisplatin works by disrupting DNA replication in cancer cells. Manufactured under GMP guidelines, it provides significant opportunities for B2B oncology pharmaceutical companies targeting hospitals, oncology clinics, and healthcare providers in both US and EU markets.